GEN and Sulfateq BV Announce Positive Phase 1 Trial Data on Investigational Drug SUL-238 for Alzheimer's and Other Neurodegenerative Diseases Pha ...

Fintel reports that on July 28, 2025, HSBC initiated coverage of Accenture (NYSE:ACN) with a Reduce recommendation. Analyst ...

Artificial intelligence tools may accelerate task completion, but they don't automatically boost productivity.

HSBC initiated coverage of Accenture (ACN) with a Reduce rating and $240 price target The firm believes the market is underestimating the ...

Accenture (NYSE: ACN) announced updates focused on reinforcing its position at the forefront of technology-driven ...

Accenture plc (NYSE:ACN) is a multinational tech company that offers information technology services and management ...

Founded on 6th of February 2013 from a merger of Nigeria's three largest opposition parties – the Action Congress of Nigeria ...

NatWest Group (NYSE:NWG) on Wednesday unveiled a five-year strategic partnership with Amazon Web Services Inc. (NASDAQ:AMZN) ...